[1] Jardine, A.G. and McLaughlin, K. (2001) Cardiovascular Complications of Renal Disease. Heart, 86, 459-466.
http://dx.doi.org/10.1136/heart.86.4.459
[2] Althaus, B.U., Staub, J.J., Ryff-De Leche, A., Oberhansli, A. and Stahelin, H.B. (1988) LDL/HDL-Changes in Subclinical Hypothyroidism: Possible Risk Factors for Coronary Heart Disease. Clinical Endocrinology (Oxford), 28, 157-163. http://dx.doi.org/10.1111/j.1365-2265.1988.tb03651.x
[3] Monzani, F., Caraccio, N., Kozakowa, M., Dardano, A., Vittone, F., Virdis, A., et al. (2004) Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism, 89, 2099-2106.
http://dx.doi.org/10.1210/jc.2003-031669
[4] Hak, A.E., Pols, H.A., Visser, T.J., Drexhage, H.A., Hofman, A. and Witteman, J.C. (2000) Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study. Annals of Internal Medicine, 132, 270-278. http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00004
[5] Galetta, F., Franzoni, F., Fallahi, P., Rossi, M., Carpi, A., Rubello, D., et al. (2006) Heart Rate Variability and QT Dispersion in Patients with Subclinical Hypothyroidism. Biomedicine & Pharmacotherapy, 60, 425-430.
http://dx.doi.org/10.1016/j.biopha.2006.07.009
[6] Schouten, E.G., Dekker, J.M., Meppelink, P., Kok, F.J., Vandenbroucke, J.P. and Pool, J. (1991) QT interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population. Circulation, 84, 1516-1523.
http://dx.doi.org/10.1161/01.CIR.84.4.1516
[7] Schwartz, P.J. and Wolf, S. (1978) QT Interval Prolongation as Predictor of Sudden Death in Patients with Myocardial Infarction. Circulation, 57, 1074-1077. http://dx.doi.org/10.1161/01.CIR.57.6.1074
[8] Batchvarov, V. and Malik, M. (2000) Measurement and Interpretation of QT Dispersion. Progress in Cardiovascular Diseases, 42, 325-344. http://dx.doi.org/10.1053/pcad.2000.0420325
[9] Port, F.K. (1994) Morbidity and Mortality in Dialysis Patients. Kidney International, 46, 1728-1737.
http://dx.doi.org/10.1038/ki.1994.475
[10] Brown, J.H., Hunt, L.P., Vites, N.P., Short, C.D., Gokal, R. and Mallick, N.P. (1994) Comparative Mortality from Cardiovascular Disease in Patients with Chronic Renal Failure. Nephrology Dialysis Transplantation, 9, 1136-1142.
[11] Zaidi, M., Robert, A., Fesler, R., Derwael, C. and Brohet, C. (1997) Dispersion of Ventricular Repolarisation: A Marker of Ventricular Arrhythmias in Patients with Previous Myocardial Infarction. Heart, 78, 371-375.
[12] Algra, A., Tijssen, J.G., Roelandt, J.R., Pool, J. and Lubsen, J. (1993) Heart Rate Variability from 24-Hour Electrocardiography and the 2-Year Risk for Sudden Death. Circulation, 88, 180-185. http://dx.doi.org/10.1161/01.CIR.88.1.180
[13] Tsuji, H., Larson, M.G., Venditti Jr., F.J., Manders, E.S., Evans, J.C., Feldman, C.L., et al. (1996) Impact of Reduced Heart Rate Variability on Risk for Cardiac Events. The Framingham Heart Study. Circulation, 94, 2850-2855.
http://dx.doi.org/10.1161/01.CIR.94.11.2850
[14] Balanescu, S., Galinier, M., Fourcade, J., Dorobantu, M., Albenque, J.P., Massabuau, P., et al. (1996) Correlation between QT Interval Dispersion and Ventricular Arrhythmia in Hypertension. Archives des Maladies du Coeur et des Vaisseaux, 89, 987-990.
[15] Bakiner, O., Ertorer, M.E., Haydardedeoglu, F.E., Bozkirli, E., Tutuncu, N.B. and Demirag, N.G. (2008) Subclinical Hypothyroidism Is Characterized by Increased QT Interval Dispersion among Women. Medical Principles and Practice, 17, 390-394. http://dx.doi.org/10.1159/000141503
[16] Hii, J.T., Wyse, D.G., Gillis, A.M., Duff, H.J., Solylo, M.A. and Mitchell, L.B. (1992) Precordial QT Interval Dispersion as a Marker of Torsade de Pointes. Disparate Effects of Class Ia Antiarrhythmic Drugs and Amiodarone. Circulation, 86, 1376-1382. http://dx.doi.org/10.1161/01.CIR.86.5.1376
[17] Yunus, A., Gillis, A.M., Duff, H.J., Wyse, D.G. and Mitchell, L.B. (1996) Increased Precordial QTc Dispersion Predicts Ventricular Fibrillation during Acute Myocardial Infarction. American Journal of Cardiology, 78, 706-708.
http://dx.doi.org/10.1016/S0002-9149(96)00405-5
[18] Zareba, W., Moss, A.J. and le Cessie, S. (1994) Dispersion of Ventricular Repolarization and Arrhythmic Cardiac Death in Coronary Artery Disease. American Journal of Cardiology, 74, 550-553.
http://dx.doi.org/10.1016/0002-9149(94)90742-0
[19] Naas, A.A., Davidson, N.C., Thompson, C., Cummings, F., Ogston, S.A., Jung, R.T., et al. (1998) QT and QTc Dispersion Are Accurate Predictors of Cardiac Death in Newly Diagnosed Non-Insulin Dependent Diabetes: Cohort Study. BMJ, 316, 745-746. http://dx.doi.org/10.1136/bmj.316.7133.745
[20] Kweon, K.H., Park, B.H. and Cho, C.G. (2007) The Effects of L-Thyroxine Treatment on QT Dispersion in Primary Hypothyroidism. Journal of Korean Medical Science, 22, 114-116. http://dx.doi.org/10.3346/jkms.2007.22.1.114
[21] de Bruyne, M.C., Hoes, A.W., Kors, J.A., Hofman, A., van Bemmel, J.H. and Grobbee, D.E. (1998) QTc Dispersion Predicts Cardiac Mortality in the Elderly: The Rotterdam Study. Circulation, 97, 467-472.
http://dx.doi.org/10.1161/01.CIR.97.5.467
[22] Okin, P.M., Devereux, R.B., Howard, B.V., Fabsitz, R.R., Lee, E.T. and Welty, T.K. (2000) Assessment of QT Interval and QT Dispersion for Prediction of All-Cause and Cardiovascular Mortality in American Indians: The Strong Heart Study. Circulation, 101, 61-66. http://dx.doi.org/10.1161/01.CIR.101.1.61
[23] Somberg, J.C. and Molnar, J. (2002) Usefulness of QT Dispersion as an Electrocardiographically Derived Index. American Journal of Cardiology, 89, 291-294. http://dx.doi.org/10.1016/S0002-9149(01)02230-5
[24] Lien, E.A., Nedrebo, B.G., Varhaug, J.E., Nygard, O., Aakvaag, A. and Ueland, P.M. (2000) Plasma Total Homocysteine Levels during Short-Term Iatrogenic Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism, 85, 1049-1053.
[25] Nedrebo, B.G., Nygard, O., Ueland, P.M. and Lien, E.A. (2001) Plasma Total Homocysteine in Hyper- and Hypothyroid Patients before and during 12 Months of Treatment. Clinical Chemistry, 47, 1738-1741.
[26] Chadarevian, R., Bruckert, E., Leenhardt, L., Giral, P., Ankri, A. and Turpin, G. (2001) Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism, 86, 732-737. http://dx.doi.org/10.1210/jcem.86.2.7221
[27] Welch, G.N. and Loscalzo, J. (1998) Homocysteine and Atherothrombosis. The New England Journal of Medicine, 338, 1042-1050. http://dx.doi.org/10.1056/NEJM199804093381507
[28] Cakal, B., Cakal, E., Demirbas, B., Ozkaya, M., Karaahmetoglu, S., Serter, R., et al. (2007) Homocysteine and Fibrinogen Changes with L-Thyroxine in Subclinical Hypothyroid Patients. Journal of Korean Medical Science, 22, 431-435. http://dx.doi.org/10.3346/jkms.2007.22.3.431
[29] Turhan, S., Sezer, S., Erden, G., Guctekin, A., Ucar, F., Ginis, Z., et al. (2008) Plasma Homocysteine Concentrations and serum Lipid Profile as Atherosclerotic Risk Factors in Subclinical Hypothyroidism. Annals of Saudi Medicine, 28, 96-101. http://dx.doi.org/10.4103/0256-4947.51750